Growth Metrics

Outlook Therapeutics (OTLK) Receivables - Other (2016)

Outlook Therapeutics (OTLK) has disclosed Receivables - Other for 2 consecutive years, with $43350.0 as the latest value for Q2 2016.

  • On a quarterly basis, Receivables - Other changed N/A to $43350.0 in Q2 2016 year-over-year; TTM through Jun 2016 was $43350.0, a N/A change, with the full-year FY2015 number at $117506.0, changed N/A from a year prior.
  • Receivables - Other was $43350.0 for Q2 2016 at Outlook Therapeutics, roughly flat from $43187.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $117506.0 in Q3 2015 to a low of $43187.0 in Q1 2016.